 |
| |
|
|
| |
| Pfizer Ranks Among Top Multinational Companies in Asia |
| |
BEIJING, October 30, 2009 – Pfizer, the world’s leading biopharmaceutical company, last night received an award by The Wall Street Journal for its strong leadership in Asia.
Ranked among the top 80 Multinational companies in the region by The Wall Street Journal Asia 200 Survey, Pfizer has been recognized for its stellar achievements in the following leadership areas:
Innovation Long-term vision Quality Corporate reputation Financial reputation
“As the leading biopharmaceutical company in Asia, Pfizer works hard to meet the diverse medical needs of people throughout the region in an innovative, socially responsible and commercially viable manner” said Dr. Wu Xiaobing, Pfizer’s country manager for China. “Through bold and innovative partnerships and practices, we are reaching more people with a wider range of high-quality products and services for every stage of life. I am pleased that our hard work in these areas has been recognized by such a prestigious organization as the Wall Street Journal.”
Dr. Wu accepted the award on behalf of the company at an Awards Ceremony in Beijing.
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
‘Working for a healthier world’ is Pfizer’s corporate signature. It
comes to life by discovering and developing innovative medicines;
making them available to patients; educating and empowering consumers
to lead longer, healthier and happier lives; partnering with government
and private institutions on public health programs; and leading in
corporate responsibility.
Pfizer ‘Working for a healthier world’ is realized in the 38 million
patients it helps everyday around the world, in the more than 100,000
people it employs, in the skills of more than 12,000 medical researchers
it utilizes, and in the partnerships with governments and healthcare
organizations it works with.
|
|
|
| |
|
|
|
|
